======= NHLRC2 ======= == Gene Information == * **Official Symbol**: NHLRC2 * **Official Name**: NHL repeat containing 2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=374354|374354]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8NBF2|Q8NBF2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NHLRC2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NHLRC2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/618277|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |NHL| |platelet alpha granule lumen| |cell redox homeostasis| |platelet degranulation| |regulated exocytosis| |exocytosis| |cellular homeostasis| |secretion by cell| |export from cell| |secretion| |homeostatic process| |extracellular region| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp344|Chlorpromazine 10μM R07 exp344]]|-2.34| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|-2.21| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|-2.2| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-2.16| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-2.13| |[[:results:exp69|Deguelin 0.05μM R02 exp69]]|-2.11| |[[:results:exp390|Pifithrin-alpha 20μM R07 exp390]]|-2.1| |[[:results:exp220|BAY-598 4μM R05 exp220]]|-2.05| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.93| |[[:results:exp517|Quercetin 20μM R08 exp517]]|-1.92| |[[:results:exp151|SGC0946 7μM R03 exp151]]|-1.9| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|-1.85| |[[:results:exp170|Metformin 100 to 150μM on day4 R04 exp170]]|-1.81| |[[:results:exp306|Rapamycin 2μM R07 exp306]]|-1.81| |[[:results:exp415|Trichostatin-A 0.06μM R07 exp415]]|-1.81| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.76| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-1.74| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.7| |[[:results:exp155|UNC1999 2μM R03 exp155]]|-1.7| |[[:results:exp349|Cytochalasin-B 5μM R07 exp349]]|1.71| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|1.96| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|2.09| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.484| |[[:human genes:r:rptor|RPTOR]]|0.448| |[[:human genes:p:pelo|PELO]]|0.444| |[[:human genes:m:meaf6|MEAF6]]|0.439| |[[:human genes:r:rtcb|RTCB]]|0.415| |[[:human genes:c:c14orf80|C14orf80]]|0.41| |[[:human genes:l:lsmd1|LSMD1]]|0.407| |[[:human genes:u:uap1|UAP1]]|0.405| Global Fraction of Cell Lines Where Essential: 397/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|15/28| |blood|12/28| |bone|11/26| |breast|13/33| |central nervous system|39/56| |cervix|3/4| |colorectal|7/17| |esophagus|4/13| |fibroblast|1/1| |gastric|10/16| |kidney|12/21| |liver|14/20| |lung|41/75| |lymphocyte|3/16| |ovary|8/26| |pancreas|13/24| |peripheral nervous system|13/16| |plasma cell|8/15| |prostate|1/1| |skin|18/24| |soft tissue|6/9| |thyroid|2/2| |upper aerodigestive|7/22| |urinary tract|17/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1310 * **Expression level (log2 read counts)**: 6.12 {{:chemogenomics:nalm6 dist.png?nolink |}}